Skip to main content
. 2019 Aug 17;20(16):4014. doi: 10.3390/ijms20164014

Table 2.

TASK-3 modulators with different chemical characteristics were used for the generation of the energy-optimized pharmacophore.

Blocker ID TASK-3 IC50 (μM) Reference
graphic file with name ijms-20-04014-i001.jpg 12f 0.074 [25]
graphic file with name ijms-20-04014-i002.jpg 17e 0.57 [25]
graphic file with name ijms-20-04014-i003.jpg 23 0.035 [6,25]
graphic file with name ijms-20-04014-i004.jpg A1899 1.6 [6,30]
graphic file with name ijms-20-04014-i005.jpg Dihydro-Beta-erythroidine 73.8 [32]
graphic file with name ijms-20-04014-i006.jpg Doxapram 23.1 [6]
graphic file with name ijms-20-04014-i007.jpg GW2974 50.1 [32]
graphic file with name ijms-20-04014-i008.jpg L-703,606 45.5 [32]
graphic file with name ijms-20-04014-i009.jpg Loratadine 63.4 [32]
graphic file with name ijms-20-04014-i010.jpg Mevastatin 159 [32]
graphic file with name ijms-20-04014-i011.jpg Mibefradil 24.6 [32]
graphic file with name ijms-20-04014-i012.jpg Octoclothepin 73.8 [32]